- Index hide
According to Statista, The global stem cell market was valued at about US$6.87 billion in 2016.
The total global stem cell therapy market was valued at around US$755 million in 2018.
A man, known as the Düsseldorf patient, has become the third case of being cured of HIV infection in the world, after receiving a stem cell transplant to treat myeloid leukemia.
Four years after having undergone the stem cell transplant, and despite the interruption of antiretroviral therapy against HIV, the patient is free of the virus, as detailed in a study recently published in the journal Nature Medicine.
Who is the third person to be cured of HIV?
A 53-year-old man, whose name was not released, was diagnosed with HIV in 2008 and three years later with acute myeloid leukemia, a potentially deadly type of blood cancer.
In 2013 the patient underwent a bone marrow transplant using stem cells from a donor with a rare mutation in the CCR5 gene, which prevents HIV from entering cells.
The Düsseldorf patient had stopped HIV antiretroviral therapy in 2018. Four years later, consistent tests found no trace of HIV in his body. The study He stated that “this third case of HIV-1 cure” provides “valuable insights that we hope will guide future cure strategies.”
What are Stem cells?
According to the Mayo Clinic, stem cells are the raw material of the body; from them all other cells with specialized functions are generated. Under the right conditions in the body or in a laboratory, stem cells divide to form more cells called daughter cells.
These daughter cells become new stem cells or specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells, or bone cells. No other cell in the body has the natural ability to generate new types of cells.
Related notes: